PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?

With the extension of life span in recent decades, there is an increasing burden of late-onset neurodegenerative diseases, for which effective treatments are lacking. Neurodegenerative diseases include the widespread Alzheimer’s disease (AD) and Parkinson’s disease (PD), the less frequent Huntington...

Descripción completa

Detalles Bibliográficos
Autores principales: Shacham, Talya, Patel, Chaitanya, Lederkremer, Gerardo Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996871/
https://www.ncbi.nlm.nih.gov/pubmed/33652720
http://dx.doi.org/10.3390/biom11030354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996871/
https://www.ncbi.nlm.nih.gov/pubmed/33652720
http://dx.doi.org/10.3390/biom11030354

Ejemplares similares